KORU Medical Systems Statistics
Share Statistics
KORU Medical Systems has 45.84M shares outstanding. The number of shares has increased by 0.41% in one year.
| Shares Outstanding | 45.84M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.2% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 43.11M |
| Failed to Deliver (FTD) Shares | 33 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 486.92K, so 1.06% of the outstanding shares have been sold short.
| Short Interest | 486.92K |
| Short % of Shares Out | 1.06% |
| Short % of Float | 1.13% |
| Short Ratio (days to cover) | 11.67 |
Valuation Ratios
The PE ratio is -8.16 and the forward PE ratio is -33.
| PE Ratio | -8.16 |
| Forward PE | -33 |
| PS Ratio | 3.93 |
| Forward PS | 5.2 |
| PB Ratio | 5.51 |
| P/FCF Ratio | -19.66 |
| PEG Ratio | n/a |
Enterprise Valuation
KORU Medical Systems Inc. has an Enterprise Value (EV) of 105.14M.
| EV / Earnings | -7.65 |
| EV / Sales | 3.69 |
| EV / EBITDA | -11.19 |
| EV / EBIT | -10.24 |
| EV / FCF | -18.42 |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.55 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 1.52 |
| Cash Flow / Debt | -15.56 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.68% and return on capital (ROIC) is -58.22%.
| Return on Equity (ROE) | -0.68% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -58.22% |
| Revenue Per Employee | 347.78K |
| Profits Per Employee | -167.57K |
| Employee Count | 82 |
| Asset Turnover | 1 |
| Inventory Turnover | 3.39 |
Taxes
| Income Tax | 3.97M |
| Effective Tax Rate | -0.41 |
Stock Price Statistics
The stock price has increased by 80.51% in the last 52 weeks. The beta is 0.41, so KORU Medical Systems 's price volatility has been higher than the market average.
| Beta | 0.41 |
| 52-Week Price Change | 80.51% |
| 50-Day Moving Average | 3.1 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 70.84 |
| Average Volume (20 Days) | 70.07K |
Income Statement
In the last 12 months, KORU Medical Systems had revenue of $28.52M and earned -$13.74M in profits. Earnings per share was $-0.3.
| Revenue | 28.52M |
| Gross Profit | 16.71M |
| Operating Income | -10.27M |
| Net Income | -13.74M |
| EBITDA | -9.40M |
| EBIT | -10.27M |
| Earnings Per Share (EPS) | -0.3 |
Balance Sheet
The company has $11.48M in cash and $4.45M in debt, giving a net cash position of $7.04M.
| Cash & Cash Equivalents | 11.48M |
| Total Debt | 4.45M |
| Net Cash | 7.04M |
| Retained Earnings | -23.31M |
| Total Assets | 27.39M |
| Working Capital | 12.60M |
Cash Flow
In the last 12 months, operating cash flow was -$4.89M and capital expenditures -$814.60K, giving a free cash flow of -$5.71M.
| Operating Cash Flow | -4.89M |
| Capital Expenditures | -814.60K |
| Free Cash Flow | -5.71M |
| FCF Per Share | -0.13 |
Margins
Gross margin is 58.59%, with operating and profit margins of -36.01% and -48.18%.
| Gross Margin | 58.59% |
| Operating Margin | -36.01% |
| Pretax Margin | -34.27% |
| Profit Margin | -48.18% |
| EBITDA Margin | -32.96% |
| EBIT Margin | -36.01% |
| FCF Margin | -20.01% |
Dividends & Yields
KRMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.04% |
| FCF Yield | -2.92% |
Analyst Forecast
The average price target for KRMD is $4, which is -6.1% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $4 |
| Price Target Difference | -6.1% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 10.64 |
| Piotroski F-Score | 3 |